Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sutton

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports|October 3, 2019
Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 DeglutathionylationMark M Hughes, Alexander Hooftman, Stefano Angiari, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The Journal of Experimental Medicine|February 28, 2020
A population of proinflammatory T cells coexpresses αβ and γδ T cell receptors in mice and humansSarah C Edwards, Caroline E Sutton, Kristin Ladell, et al.
Mbio|March 1, 2022
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication <i>In Vitro</i> and Decreases Viral Titers and Disease Progression in Syrian HamstersIart Luca Shytaj, Mohamed Fares, Lara Gallucci, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Cell Reports|October 3, 2019
Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 DeglutathionylationMark M Hughes, Alexander Hooftman, Stefano Angiari, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The Journal of Experimental Medicine|February 28, 2020
A population of proinflammatory T cells coexpresses αβ and γδ T cell receptors in mice and humansSarah C Edwards, Caroline E Sutton, Kristin Ladell, et al.
Mbio|March 1, 2022
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication <i>In Vitro</i> and Decreases Viral Titers and Disease Progression in Syrian HamstersIart Luca Shytaj, Mohamed Fares, Lara Gallucci, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike proteinSeth J Zost, Pavlo Gilchuk, Rita E Chen, et al.
Cell Reports. Medicine|May 31, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functionsAndrea R Shiakolas, Kevin J Kramer, Daniel Wrapp, et al.
Pageof 29